Greg Fodell

Greg Fodell is an accomplished financial executive with extensive experience in corporate development and investment, currently serving as Chief Investment Officer at PharmaCann Inc since April 2024. Prior to this role, Greg held the position of VP, Corporate Development at Connected Cannabis Co. from September 2021 to April 2024 and served as Director of Corporate Development at PharmaCann Inc. from May 2017 to September 2021. Greg’s career includes significant roles at Fitch Ratings as Director and a brief tenure as Venture Capital Associate at Motorola Solutions. Earlier experience includes positions at Deutsche Bank as an Analyst and Summer Analyst. Greg Fodell earned an MBA in Finance, Entrepreneurship, and Innovation from Northwestern University's Kellogg School of Management and a BBA in Accounting and Finance from the University of Michigan's Stephen M. Ross School of Business.